Society of Hematologic Oncology

Society of Hematologic Oncology SOHO is the only global society dedicated to the research & treatment of hematologic malignancies. Join SOHO for FREE today at soho.click/join.

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders. Since that time, nearly 3,000 members have joined the society from around the globe. SOHO is led by a Board of Directors with six voting members. In addition, an outstanding group of clinician-scientists have been assembled to serve on the Steering Committee to provide guidance and direction in the continued development of SOHO. Two additional committees, Scientific and Education, are responsible for abstract review and the scientific program of the annual meetings, respectively.

“Clinical Lymphoma, Myeloma & Leukemia,” a peer-reviewed journal published by Elsevier, is the official journal of SOHO. It is available online free-of-charge to SOHO members and at a discounted rate in printed form (click the 'Sign Up' button to become a SOHO member). The SOHO Fifth Annual Meeting is scheduled for September 13-16, 2017 at the Westin Galleria and Oaks in Houston, Texas. The society expects more than 1,000 physicians and related professionals to attend the 3.5-day event. (go to soho2017.com for more information and registration).

1st SOHO Asia hopes to empower hematology community across Asia
01/24/2026

1st SOHO Asia hopes to empower hematology community across Asia

Dr. Hsin-An Hou, a professor at National Taiwan University Hospital, shares his excitement about the regional impact of the inaugural SOHO Asia meeting, held in Taipei, Taiwan, January 23–25. Dr. Hou is a SOHO Ambassador and co-organizer of SOHO Asia.

Andrew Wei discussing the treatment landscape in AML at SOHO Asia in Taipei
01/24/2026

Andrew Wei discussing the treatment landscape in AML at SOHO Asia in Taipei

SOHO Asia in Taipei starts Friday🎉🥳
01/22/2026

SOHO Asia in Taipei starts Friday🎉🥳

Community Oncology Brown Bag Series Sharing clinical experience to support collective learningJoin SOHO Insider, the off...
01/21/2026

Community Oncology Brown Bag Series
Sharing clinical experience to support collective learning

Join SOHO Insider, the official media platform of the Society of Hematologic Oncology, for the inaugural Virtual Community Oncology Brown Bag Series, an informal lunchtime discussion program featuring community oncologists sharing real-world experiences from practice.

The program will be led and developed by Loretta J. Nastoupil, MD, our SOHO Insider Editorial leader in community oncology.

Registration is free and open to the public. All sessions are held on Zoom. Register at https://soho.click/community-oncology-series

Tara Graff, DO, MS Director of Clinical Research at Mission Cancer + Blood, will present “Implementing bispecific antibodies in community practice” on February 11, 2026, from 2:00–2:30 PM CST.

Talquetamab, teclistamab combo induces responses in patients with extramedullary myeloma
01/20/2026

Talquetamab, teclistamab combo induces responses in patients with extramedullary myeloma

Phase 2 results of the RedirecTT-1 study showed that treatment with talquetamab and teclistamab in patients with drug-resistant, true extramedullary myeloma induced a response in 79%. The 12-month overall survival rate was 74%. “Our findings offer valuable data for treatment in a population that i...

Our new print feature follows the journey of cilta-cel and the first American to be dosed with the cellular therapy in C...
01/14/2026

Our new print feature follows the journey of cilta-cel and the first American to be dosed with the cellular therapy in China.

By the time Craig Chase, a father of two boys who lives in the San Francisco Bay Area, boarded a flight to China in 2017 to join a clinical trial testing an experimental therapy for his multiple myeloma, he had already exhausted nearly all treatment options. “I was at the end of my rope,” he sai...

Triplet therapy shows efficacy, tolerability, and transplant potential in BPDCN
01/12/2026

Triplet therapy shows efficacy, tolerability, and transplant potential in BPDCN

Tagraxofusp, azacitidine, and venetoclax (TAG-AZA-VEN) triplet therapy shows efficacy, tolerability, and transplant potential in patients with blastic plasmacytoid dendritic cell neoplasm, according to the results of a phase 2 trial presented during the 67th American Society of Hematology Annual Mee...

Watch our video interview on DOCK1 inhibition in TP53-mutant clonal hematopoiesis
01/08/2026

Watch our video interview on DOCK1 inhibition in TP53-mutant clonal hematopoiesis

Recorded at the 67th American Society of Hematology Annual Meeting and Exposition, Yang Feng, PhD, discusses her ASH abstract titled (No.631) “Targeting DOCK...

Address

The Woodlands, TX
77393

Opening Hours

Monday 8am - 6pm
Tuesday 8am - 6pm
Wednesday 8am - 6pm
Thursday 8am - 6pm
Friday 8am - 6pm

Telephone

+12813647387

Website

http://soho.click/2026, http://sohoinsider.com/, http://sohoonline.org/

Alerts

Be the first to know and let us send you an email when Society of Hematologic Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Society of Hematologic Oncology:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

About the Society

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders. Since that time, nearly 3,000 members have joined the society from around the globe. SOHO is led by a Board of Directors with eight voting members. In addition, an outstanding group of clinician-scientists have been assembled to serve on the Steering Committee to provide guidance and direction in the continued development of SOHO. Two additional committees, Scientific and Education, are responsible for abstract review and the scientific program of the annual meetings, respectively. “Clinical Lymphoma, Myeloma & Leukemia,” a peer-reviewed journal published by Elsevier, is the official journal of SOHO. It is available online free-of-charge to SOHO members and at a discounted rate in printed form (click the 'Sign Up' button to become a SOHO member). The SOHO Sixth Annual Meeting is scheduled for September 12-15, 2018 at the Hilton Americas-Houston in Houston, Texas. The society expects approximately 1,200 physicians and related professionals to attend the 3.5-day event. (go to soho2018.org for more information, abstract submissions and registration).